Archives: CME Programming

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

This online activity is focused on the identification and exploration of immune-related adverse events, their management, and the critical role of emergency department physicians in the care of patients treated with immune checkpoint inhibitors.

Release Date: February 10, 2020
Expiration Date: February 10, 2021

Considerations for Oncology Nurses—Individualizing the Management of Acute Myeloid Leukemia: Genomics, Targeted Therapeutic Options, and Treatment Sequencing

Considerations for Oncology Nurses—Individualizing the ManaThis online activity will cover the treatment and management of patients with Acute Myeloid Leukemia (AML).

This online activity will cover the treatment and management of patients with Acute Myeloid Leukemia (AML).

Release Date: December 16, 2019
Expiration Date: December 16, 2020

Improving the Management of Patients with Severe Uncontrolled Asthma

Improving the Management of Patients with Severe Uncontrolled Asthma

This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with uncontrolled asthma.

Release Date: December 10, 2019
Expiration Date: December 10, 2020

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

An Oculus Virtual Reality View: The Role of Emergency Physicians in the Management of Immune-Related Adverse Events in Patients Treated with Immuno-oncology Agents

This online activity is focused on the identification and exploration of immune-related adverse events, their management, and the critical role of emergency department physicians in the care of patients treated with immune checkpoint inhibitors.

Release Date: November 21, 2019
Expiration Date: November 21, 2020

The THRIVE Beyond Glycemic Control Initiative: A Spotlight on Hypoglycemia: Reducing Risks Without Compromising Glycemic Control

This enduring activity will cover ways in which the healthcare team can minimize the risk for hypoglycemia in patients with type 2 diabetes. Specifically, our aims will be to review the consequences of hypoglycemia; discuss approaches to assessing symptomatic and asymptomatic risk of hypoglycemia; assess anti-diabetes therapies and how to balance their safety and efficacy to reduce hypoglycemia; and evaluate nonpharmacological strategies for lowering risk.

Release Date: September 27, 2019
Expiration Date: September 27, 2020

3D Tour of Immuno-Oncology: Bladder Cancer

A 3D Tour of Immuno-Oncology: Bladder Cancer

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Release Date: August 28, 2019
Expiration Date: August 28, 2020

A 3D Tour of Immuno-Oncology: Melanoma

A 3D Tour of Immuno-Oncology: Melanoma

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Release Date: August 28, 2019
Expiration Date: August 28, 2020

Biomarkers for Immunotherapies Across Tumor Types

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Release Date: May 30, 2019
Expiration Date: May 30, 2020

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 5: Response to Therapy and Management of Adverse Events from Targeted and Immuno-Therapies

This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Release Date: May 29, 2019
Expiration Date: May 29, 2020

Tumor Mutational Burden and Microsatellite Instability

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Release Date: May 21, 2019
Expiration Date: May 21, 2020

A Virtual Reality View Gonadotropin-releasing Hormone-based Therapies for the Treatment of Endometriosis-related Pain

In this online activity, we will take an in-depth look at therapeutic options for patients with endometriosis-related pain, as well as evidence-based guidelines for treatment. We will cover several patient-related aspects of care, such as considerations based on age, severity, treatment preference, and comorbidities. Finally, we will focus on findings from clinical trials of GnRH-based therapies for endometriosis pain.

Release Date: May 15, 2019
Expiration Date: May 15, 2020

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 4: Investigational Treatment

This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Release Date: May 13, 2019
Expiration Date: May 13, 2020

A 3D Tour of Immuno-Oncology – Adverse Events

This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.

Release Date: April 29, 2019
Expiration Date: April 29, 2020

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 3: Resistance or Nonresponse to Treatment

This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Release Date: April 19, 2019
Expiration Date: April 19, 2020

Part 2 An In-Practice View: Moving Beyond Statins to Decrease Cardiovascular Events in Patients With Atherosclerotic Disease

This online activity will look at chronic hypercholesterolemia as a pathogenic factor in cardiovascular disease. With a focus on PCSK9- inhibitor therapy, the talk will assess clinical trials and cardiovascular outcomes against the backdrop of residual cardiovascular risk in patients on maximally tolerated statin therapy.

Release Date: April 1, 2019
Expiration Date: April 1, 2020

Part 1 An In-Practice View: Moving Beyond Statins to Decrease Cardiovascular Events in Patients With Atherosclerotic Disease

This online activity will look at chronic hypercholesterolemia as a pathogenic factor in cardiovascular disease. The talk will assess hypotheses in atherosclerotic plaque formation and discuss the implications of residual cardiovascular risk in patients intolerant to statins or on maximally-tolerated statin doses.

Release Date: April 1, 2019
Expiration Date: April 1, 2020

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 2: Mechanisms of Immune Escape

This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Release Date: March 29, 2019
Expiration Date: March 29, 2020

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 1: An Overview of Immuno-Oncolog

This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Release Date: March 27, 2019
Expiration Date: March 27, 2020

Managing High-Risk Cutaneous SCC

This case-based activity will cover the treatment and management of patients with cancer who are treated with or are eligible for treatment with recurrent or cutaneous squamous cell carcinoma.

Release Date: March 20, 2019
Expiration Date: March 20, 2020

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.